Sharps Technology (STSS) announced the pricing of a firm commitment underwritten public offering with gross proceeds to the Company expected to be approximately $20M, before deducting underwriting fees and other estimated offering expenses payable by the Company. The offering consists of 14,285,714 Common Units, each consisting of one share of Common Stock or one Pre-Funded Warrant, one Series A Registered Common Warrant to purchase one share of Common Stock per warrant at an exercise price of $1.75 and one Series B Registered Common Warrant to purchase one share of Common Stock per warrant at an exercise price of $1.75. The public offering price per Common Unit is $1.40. The Pre-Funded Warrants will be immediately exercisable and may be exercised at any time until exercised in full. For each Pre-Funded Unit sold in the offering, the number of Common Units in the offering will be decreased on a one-for-one basis. The initial exercise price of each Series A Warrant is $1.75 per share of Common Stock. The Series A Warrants are exercisable immediately and expire 60 months after stockholder approval. The number of securities issuable under the Series A Warrants is subject to adjustment as described in more detail in the report on Form 8-K to be filed in connection with the offering. The initial exercise price of each Series B Warrant is $1.75 per share of Common Stock or pursuant to an alternative cashless exercise option. The Series B Warrants are exercisable immediately and expire 30 months after stockholder approval. The number of securities issuable under the Series B Warrants is subject to adjustment as described in more detail in the report on Form 8-K to be filed in connection with the offering. Solely to cover over-allotments, if any, the Company has granted Aegis Capital a 45-day option to purchase additional shares of Common Stock and/or Warrants of up to 15.0% of the number of shares of Common Stock sold in the offering, up to 15.0% of the number of Series A Warrants sold in the offering and up to 15.0% of the number of Series B Warrants sold in the offering. The purchase price to be paid per additional share of Common Stock will be equal to the public offering price of one Common Unit, less the underwriting discount. The purchase price to be paid per additional Warrant will be $0.00001. Aggregate gross proceeds to the Company are expected to be approximately $20M. The transaction is expected to close on or about January 29, 2025, subject to the satisfaction of customary closing conditions. The Company expects to use the net proceeds from the offering, together with its existing cash, for general corporate purposes and working capital. Aegis Capital Corp. is acting as the sole book-running manager for the offering.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on STSS:
- Sharps Technology files to sell 6.73M units
- Sharps Technology files to sell 37,013 shares of common stock for holders
- Sharps Technology Expands Hungary Facility for Growth
- Sharps Technology Expands with European Sales Agreements
- Sharps signs sales agreement to support major European healthcare network